Ranitidine Appeal After a Defense Verdict Falls Flat in Illinois

Litigation attorney Eric Alexander published a blog for Drug & Device Law analyzing the recent Illinois appellate court decision in Valadez v. GlaxoSmithKline LLC, which affirmed a defense verdict in a ranitidine-related product liability case. Mr. Alexander explains how the court upheld the preemption of strict liability failure to warn and design defect claims against generic manufacturers and retailers, reinforcing the legal principle that federal law requires generic drug labeling and design to match the brand-name reference product. The blog also discusses the court's rejection of novel negligence claims related to transportation and storage, highlighting continuing judicial scrutiny of plaintiff efforts to circumvent federal preemption in ranitidine litigation. This decision underscores the challenges plaintiffs face in pursuing ranitidine claims in state courts after repeated defense victories in federal litigation.

READ: Ranitidine Appeal After a Defense Verdict Falls Flat in Illinois